SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Dafydd, I.S. Whitaker, M.S. Murison, D.E. Boyce, Change in operative workload for rheumatoid disease of the hand: 1,109 procedures over 13 years, Journal of Plastic, Reconstructive & Aesthetic Surgery, 2012, 65, 6, 800

    CrossRef

  2. 2
    Amit Jain, Benjamin E. Stein, Richard L. Skolasky, Lynne C. Jones, Marc W. Hungerford, Total Joint Arthroplasty in Patients With Rheumatoid Arthritis, The Journal of Arthroplasty, 2012, 27, 6, 881

    CrossRef

  3. 3
    Nasim A Khan, Tuulikki Sokka, Declining needs for total joint replacements for rheumatoid arthritis, Arthritis Research & Therapy, 2011, 13, 5, 130

    CrossRef

  4. 4
    Anne Boer, Debbie Melchers, Sylvia Vink, Friedo Dekker, Liesbeth Beaart, Zuzana Jong, Real patient learning integrated in a preclinical block musculoskeletal disorders. Does it make a difference?, Clinical Rheumatology, 2011, 30, 8, 1029

    CrossRef

  5. 5
    Nobuyuki Takahashi, Kaneshige Sasaki, Takeshi Nishiyama, Taio Naniwa, Satisfaction and attitudes toward therapy in patients with rheumatoid arthritis, Modern Rheumatology, 2011,

    CrossRef

  6. 6
    Suzanne M.M. Verstappen, Deborah P.M. Symmons, What is the outcome of RA in 2011 and can we predict it?, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 485

    CrossRef

  7. 7
    MK Söderlin, Y Lindroth, C Turesson, LTH Jacobsson, A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmö, Sweden, 1997–2005, Scandinavian Journal of Rheumatology, 2010, 39, 3, 206

    CrossRef

  8. 8
    Tuulikki Sokka, How Should Rheumatoid Arthritis Disease Activity Be Measured Today and in the Future in Clinical Care?, Rheumatic Disease Clinics of North America, 2010, 36, 2, 243

    CrossRef

  9. 9
    J. A. B. van Nies, Z. de Jong, A. H. M. van der Helm-van Mil, R. Knevel, S. Le Cessie, T. W. J. Huizinga, Improved treatment strategies reduce the increased mortality risk in early RA patients, Rheumatology, 2010, 49, 11, 2210

    CrossRef

  10. 10
    S Shankar, “DMARD naïve period” in treatment of rheumatoid arthritis: a different story, Indian Journal of Rheumatology, 2009, 4, 3, 87

    CrossRef

  11. 11
    U. Bergstrom, L. T. H. Jacobsson, C. Turesson, Cardiovascular morbidity and mortality remain similar in two cohorts of patients with long-standing rheumatoid arthritis seen in 1978 and 1995 in Malmo, Sweden, Rheumatology, 2009, 48, 12, 1600

    CrossRef

  12. 12
    Tuulikki Sokka, Heidi Mäkinen, Drug management of early rheumatoid arthritis – 2008, Best Practice & Research Clinical Rheumatology, 2009, 23, 1, 93

    CrossRef

  13. 13
    Tuulikki Sokka, Influence of gender on the symptoms and severity of rheumatoid arthritis: do women suffer more?, International Journal of Clinical Rheumatology, 2009, 4, 3, 245

    CrossRef

  14. 14
    Till Uhlig, Tore K. Kvien, Is rheumatoid arthritis really getting less severe?, Nature Reviews Rheumatology, 2009, 5, 8, 461

    CrossRef

  15. 15
    Tuulikki Sokka, Long-term outcomes of rheumatoid arthritis, Current Opinion in Rheumatology, 2009, 21, 3, 284

    CrossRef

  16. 16
    Tuulikki Sokka, Theodore Pincus, Rheumatoid arthritis: strategy more important than agent, The Lancet, 2009, 374, 9688, 430

    CrossRef

  17. 17
    Theodore Pincus, Christopher J. Swearingen, The HAQ Compared with the MDHAQ: “Keep It Simple, Stupid” (KISS), with Feasibility and Clinical Value as Primary Criteria for Patient Questionnaires in Usual Clinical Care, Rheumatic Disease Clinics of North America, 2009, 35, 4, 787

    CrossRef

  18. 18
    Theodore Pincus, Yusuf Yazici, Tuulikki Sokka, Are excellent systematic reviews of clinical trials useful for patient care?, Nature Clinical Practice Rheumatology, 2008, 4, 6, 294

    CrossRef

  19. 19
    T. Sokka, T. Pincus, Ascendancy of weekly low-dose methotrexate in usual care of rheumatoid arthritis from 1980 to 2004 at two sites in Finland and the United States, Rheumatology, 2008, 47, 10, 1543

    CrossRef

  20. 20
    B. Fautrel, R. M. Flipo, A. Saraux, Eligibility of rheumatoid arthritis patients for anti-TNF-  therapy according to the 2005 recommendations of the French and British Societies for Rheumatology, Rheumatology, 2008, 47, 11, 1698

    CrossRef

  21. 21
    Fumio Shinomiya, Noriaki Mima, Keiichirou Nanba, Kenji Tani, Shunji Nakano, Hiroshi Egawa, Toshinori Sakai, Hideaki Miyoshi, Daisuke Hamada, Life expectancies of Japanese patients with rheumatoid arthritis: a review of deaths over a 20-year period, Modern Rheumatology, 2008, 18, 2, 165

    CrossRef

  22. 22
    Jackie Nam, Edith Villeneuve, Paul Emery, Predicting the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis, Future Rheumatology, 2008, 3, 5, 441

    CrossRef

  23. 23
    Cecilia P. Chung, Annette Oeser, Joseph F. Solus, Ingrid Avalos, Tebeb Gebretsadik, Ayumi Shintani, Paolo Raggi, Tuulikki Sokka, Theodore Pincus, C. Michael Stein, Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis, Atherosclerosis, 2008, 196, 2, 756

    CrossRef

  24. 24
    Tuulikki Sokka, Merete Lund Hetland, Heidi Mäkinen, Hannu Kautiainen, Kim Hørslev-Petersen, Reijo K. Luukkainen, Bernard Combe, Humeira Badsha, Alexandros A. Drosos, Joe Devlin, Gianfranco Ferraccioli, Alessia Morelli, Monique Hoekstra, Maria Majdan, Stefan Sadkiewicz, Miguel Belmonte, Ann-Carin Holmqvist, Ernest Choy, Gerd R. Burmester, Recep Tunc, Aleksander Dimić, Jovan Nedović, Aleksandra Stanković, Martin Bergman, Sergio Toloza, Theodore Pincus, Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries, Arthritis & Rheumatism, 2008, 58, 9
  25. 25
    Edith Villeneuve, Paul Emery, Rheumatoid arthritis: what has changed?, Skeletal Radiology, 2008, 38, 2, 109

    CrossRef

  26. 26
    Tuulikki Sokka, Minja Envalds, Theodore Pincus, Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs, Modern Rheumatology, 2008, 18, 3, 228

    CrossRef

  27. 27
    Yasser EL MIEDANY, Maha EL GAAFARY, Sally S. YOUSSEF, Ihab AHMED, Validity of the Developed Arabic Multidimensional Health Assessment Questionnaire for use in standard clinical care of patients with rheumatic diseases, International Journal of Rheumatic Diseases, 2008, 11, 3
  28. 28
    Theodore Pincus, Yusuf Yazici, Martin Bergman, Ross Maclean, Timothy Harrington, A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ), Best Practice & Research Clinical Rheumatology, 2007, 21, 4, 789

    CrossRef

  29. 29
    Takefumi Furuya, Masayuki Hakoda, Naomi Ichikawa, Kenshi Higami, Yuki Nanke, Toru Yago, Naoyuki Kamatani, Shigeru Kotake, Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis, Clinical Rheumatology, 2007, 26, 12, 2137

    CrossRef

  30. 30
    Piet L.C.M. van Riel, J. Fransen, Established rheumatoid arthritis: clinical assessments, Best Practice & Research Clinical Rheumatology, 2007, 21, 5, 807

    CrossRef

  31. 31
    Tuulikki Sokka, Theodore Pincus, Expanding quantitative assessment of rheumatoid arthritis in usual care, Future Rheumatology, 2007, 2, 5, 469

    CrossRef

  32. 32
    Hisashi Yamanaka, Eisuke Inoue, Gurkirpal Singh, Eiichi Tanaka, Ayako Nakajima, Atsuo Taniguchi, Masako Hara, Taisuke Tomatsu, Naoyuki Kamatani, Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan, Modern Rheumatology, 2007, 17, 4, 283

    CrossRef

  33. 33
    Tuulikki Sokka, Is the long-term outcome of rheumatoid arthritis improving? Evidence from total joint replacement surgery, Future Rheumatology, 2007, 2, 3, 237

    CrossRef

  34. 34
    Tuulikki Sokka, Quantitative assessment of rheumatoid arthritis in standard clinical care: turning clinical care into clinical science, Best Practice & Research Clinical Rheumatology, 2007, 21, 4, 653

    CrossRef

  35. 35
    Bruno Fautrel, Thao Pham, Gaël Mouterde, Xavier Le Loët, Philippe Goupille, Francis Guillemin, Philippe Ravaud, Alain Cantagrel, Maxime Dougados, Xavier Puéchal, Jean Sibilia, Martin Soubrier, Xavier Mariette, Bernard Combe, Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde, Revue du Rhumatisme, 2007, 74, 12, 1301

    CrossRef

  36. 36
    Bruno Fautrel, Thao Pham, Gaël Mouterde, Xavier Le Loët, Philippe Goupille, Francis Guillemin, Philippe Ravaud, Alain Cantagrel, Maxime Dougados, Xavier Puéchal, Jean Sibilia, Martin Soubrier, Xavier Mariette, Bernard Combe, Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with rheumatoid arthritis, Joint Bone Spine, 2007, 74, 6, 627

    CrossRef

  37. 37
    Murat Birtane, Derya Demirbag Kabayel, Kaan Uzunca, Ercument Unlu, Nurettin Tastekin, The relation of hand functions with radiological damage and disease activity in rheumatoid arthritis, Rheumatology International, 2007, 28, 5, 407

    CrossRef

  38. 38
    Tuulikki Sokka, Hannu Kautiainen, Pekka Hannonen, Theodore Pincus, Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population, Arthritis & Rheumatism, 2006, 54, 10
  39. 39
    Jenny Augustsson, Thorunn Jonsdottir, Lars Klareskog, Ronald F van Vollenhoven, Infliximab in the treatment of rheumatoid arthritis, Aging Health, 2006, 2, 1, 19

    CrossRef

  40. 40
    Bruno Fautrel, Arnaud Constantin, Jacques Morel, Olivier Vittecoq, Alain Cantagrel, Bernard Combe, Maxime Dougados, Xavier Le Loët, Xavier Mariette, Thao Pham, Xavier Puéchal, Jean Sibilia, Martin Soubrier, Philippe Ravaud, Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde, Revue du Rhumatisme, 2006, 73, 7, 726

    CrossRef

  41. 41
    Bruno Fautrel, Arnaud Constantin, Jacques Morel, Olivier Vittecoq, Alain Cantagrel, Bernard Combe, Maxime Dougados, Xavier Le Loët, Xavier Mariette, Thao Pham, Xavier Puéchal, Jean Sibilia, Martin Soubrier, Philippe Ravaud, Recommendations of the French Society for Rheumatology. TNFα antagonist therapy in rheumatoid arthritis, Joint Bone Spine, 2006, 73, 4, 433

    CrossRef

  42. 42
    Tuulikki Sokka, Pekka Hannonen, Timo Möttönen, Conventional Disease-Modifying Antirheumatic Drugs in Early Arthritis, Rheumatic Disease Clinics of North America, 2005, 31, 4, 729

    CrossRef

  43. 43
    Till Uhlig, Tore K. Kvien, Has rheumatoid arthritis become a milder disease?, Drug Discovery Today: Disease Mechanisms, 2005, 2, 3, 331

    CrossRef

  44. 44
    Paco M. J. Welsing, Jaap Fransen, Piet L. C. M. van Riel, Is the disease course of rheumatoid arthritis becoming milder?: Time trends since 1985 in an inception cohort of early rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 9
  45. 45
    Ronald F. Van Vollenhoven, Lars Klareskog, The treatment of rheumatoid arthritis: Getting better all the time?, Arthritis & Rheumatism, 2005, 52, 4